vs
南玻集团（CSGS）与Indivior Pharmaceuticals, Inc.（INDV）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是南玻集团的1.1倍（$357.0M vs $323.1M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 2.2%，领先26.7%），南玻集团自由现金流更多（$55.8M vs $-245.0M）
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商，业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售，产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
CSGS vs INDV — 直观对比
营收规模更大
INDV
是对方的1.1倍
$323.1M
净利率更高
INDV
高出26.7%
2.2%
自由现金流更多
CSGS
多$300.8M
$-245.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $323.1M | $357.0M |
| 净利润 | $7.0M | $103.0M |
| 毛利率 | 50.0% | 82.1% |
| 营业利润率 | 9.0% | 22.7% |
| 净利率 | 2.2% | 28.9% |
| 营收同比 | 2.0% | — |
| 净利润同比 | -79.7% | 390.5% |
| 每股收益（稀释后） | $0.24 | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSGSINDV
| Q4 25 | $323.1M | $357.0M | ||
| Q3 25 | $303.6M | $314.0M | ||
| Q2 25 | $297.1M | $302.0M | ||
| Q1 25 | $299.5M | $266.0M | ||
| Q4 24 | $316.7M | — | ||
| Q3 24 | $295.1M | $307.0M | ||
| Q2 24 | $290.3M | $299.0M | ||
| Q1 24 | $295.1M | — |
净利润CSGSINDV
| Q4 25 | $7.0M | $103.0M | ||
| Q3 25 | $20.5M | $42.0M | ||
| Q2 25 | $12.3M | $18.0M | ||
| Q1 25 | $16.1M | $47.0M | ||
| Q4 24 | $34.5M | — | ||
| Q3 24 | $19.1M | $22.0M | ||
| Q2 24 | $13.8M | $-97.0M | ||
| Q1 24 | $19.5M | — |
毛利率CSGSINDV
| Q4 25 | 50.0% | 82.1% | ||
| Q3 25 | 48.1% | 73.2% | ||
| Q2 25 | 49.5% | 82.8% | ||
| Q1 25 | 48.4% | 83.1% | ||
| Q4 24 | 51.3% | — | ||
| Q3 24 | 49.4% | 78.5% | ||
| Q2 24 | 47.3% | 73.6% | ||
| Q1 24 | 46.5% | — |
营业利润率CSGSINDV
| Q4 25 | 9.0% | 22.7% | ||
| Q3 25 | 10.0% | 13.7% | ||
| Q2 25 | 10.0% | 23.8% | ||
| Q1 25 | 9.8% | 24.8% | ||
| Q4 24 | 13.4% | — | ||
| Q3 24 | 10.8% | 11.4% | ||
| Q2 24 | 8.8% | -39.5% | ||
| Q1 24 | 10.8% | — |
净利率CSGSINDV
| Q4 25 | 2.2% | 28.9% | ||
| Q3 25 | 6.7% | 13.4% | ||
| Q2 25 | 4.1% | 6.0% | ||
| Q1 25 | 5.4% | 17.7% | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 6.5% | 7.2% | ||
| Q2 24 | 4.8% | -32.4% | ||
| Q1 24 | 6.6% | — |
每股收益（稀释后）CSGSINDV
| Q4 25 | $0.24 | $0.79 | ||
| Q3 25 | $0.73 | $0.33 | ||
| Q2 25 | $0.44 | $0.14 | ||
| Q1 25 | $0.57 | $0.38 | ||
| Q4 24 | $1.20 | — | ||
| Q3 24 | $0.67 | $0.16 | ||
| Q2 24 | $0.48 | $-0.72 | ||
| Q1 24 | $0.68 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $195.0M |
| 总债务越低越好 | $539.5M | — |
| 股东权益账面价值 | $283.7M | $-98.0M |
| 总资产 | $1.5B | $1.2B |
| 负债/权益比越低杠杆越低 | 1.90× | — |
8季度趋势，按日历期对齐
现金及短期投资CSGSINDV
| Q4 25 | $180.0M | $195.0M | ||
| Q3 25 | $158.4M | $445.0M | ||
| Q2 25 | $145.9M | $510.0M | ||
| Q1 25 | $136.0M | $373.0M | ||
| Q4 24 | $161.8M | — | ||
| Q3 24 | $118.4M | — | ||
| Q2 24 | $110.4M | — | ||
| Q1 24 | $120.8M | — |
总债务CSGSINDV
| Q4 25 | $539.5M | — | ||
| Q3 25 | $538.6M | — | ||
| Q2 25 | $537.8M | — | ||
| Q1 25 | $537.6M | — | ||
| Q4 24 | $538.5M | — | ||
| Q3 24 | $539.5M | — | ||
| Q2 24 | $540.5M | — | ||
| Q1 24 | $541.5M | — |
股东权益CSGSINDV
| Q4 25 | $283.7M | $-98.0M | ||
| Q3 25 | $289.5M | $-207.0M | ||
| Q2 25 | $290.7M | $-257.0M | ||
| Q1 25 | $283.1M | $-285.0M | ||
| Q4 24 | $282.6M | — | ||
| Q3 24 | $288.4M | $-310.0M | ||
| Q2 24 | $273.3M | $-281.0M | ||
| Q1 24 | $269.3M | — |
总资产CSGSINDV
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.3B | — |
负债/权益比CSGSINDV
| Q4 25 | 1.90× | — | ||
| Q3 25 | 1.86× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 1.91× | — | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 2.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.2M | $-221.0M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | $-245.0M |
| 自由现金流率自由现金流/营收 | 17.3% | -68.6% |
| 资本支出强度资本支出/营收 | 1.1% | 6.7% |
| 现金转化率经营现金流/净利润 | 8.46× | -2.15× |
| 过去12个月自由现金流最近4个季度 | $141.4M | $-93.0M |
8季度趋势，按日历期对齐
经营现金流CSGSINDV
| Q4 25 | $59.2M | $-221.0M | ||
| Q3 25 | $47.9M | $-39.0M | ||
| Q2 25 | $37.3M | $158.0M | ||
| Q1 25 | $11.5M | $75.0M | ||
| Q4 24 | $82.5M | — | ||
| Q3 24 | $39.5M | $2.0M | ||
| Q2 24 | $43.1M | $88.0M | ||
| Q1 24 | $-29.4M | — |
自由现金流CSGSINDV
| Q4 25 | $55.8M | $-245.0M | ||
| Q3 25 | $43.9M | $-59.0M | ||
| Q2 25 | $34.6M | $141.0M | ||
| Q1 25 | $7.1M | $70.0M | ||
| Q4 24 | $76.6M | — | ||
| Q3 24 | $32.0M | $-5.0M | ||
| Q2 24 | $38.8M | $84.0M | ||
| Q1 24 | $-34.1M | — |
自由现金流率CSGSINDV
| Q4 25 | 17.3% | -68.6% | ||
| Q3 25 | 14.5% | -18.8% | ||
| Q2 25 | 11.6% | 46.7% | ||
| Q1 25 | 2.4% | 26.3% | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 10.8% | -1.6% | ||
| Q2 24 | 13.4% | 28.1% | ||
| Q1 24 | -11.6% | — |
资本支出强度CSGSINDV
| Q4 25 | 1.1% | 6.7% | ||
| Q3 25 | 1.3% | 6.4% | ||
| Q2 25 | 0.9% | 5.6% | ||
| Q1 25 | 1.5% | 1.9% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 2.5% | 2.3% | ||
| Q2 24 | 1.5% | 1.3% | ||
| Q1 24 | 1.6% | — |
现金转化率CSGSINDV
| Q4 25 | 8.46× | -2.15× | ||
| Q3 25 | 2.34× | -0.93× | ||
| Q2 25 | 3.04× | 8.78× | ||
| Q1 25 | 0.71× | 1.60× | ||
| Q4 24 | 2.39× | — | ||
| Q3 24 | 2.07× | 0.09× | ||
| Q2 24 | 3.12× | — | ||
| Q1 24 | -1.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
